Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 33417

1.

Outcome of bariatric surgery in patients with type 1 diabetes mellitus: our experience and review of the literature.

Rottenstreich A, Keidar A, Yuval JB, Abu-Gazala M, Khalaileh A, Elazary R.

Surg Endosc. 2016 Apr 28. [Epub ahead of print]

PMID:
27126622
2.

Early Pharmacodynamic Effects of Exenatide Once Weekly in Type 2 Diabetes Are Independent of Weight Loss: A Pooled Analysis of Patient-Level Data.

Trautmann ME, Han J, Ruggles J.

Clin Ther. 2016 Apr 25. pii: S0149-2918(16)30185-0. doi: 10.1016/j.clinthera.2016.03.039. [Epub ahead of print]

PMID:
27126504
3.

The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond.

João AL, Reis F, Fernandes R.

Obes Rev. 2016 Apr 29. doi: 10.1111/obr.12421. [Epub ahead of print] Review.

PMID:
27125902
4.

Combinational strategies of metformin and chemotherapy in cancers.

Zhang HH, Guo XL.

Cancer Chemother Pharmacol. 2016 Apr 27. [Epub ahead of print] Review.

PMID:
27118574
5.

Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus.

Wong RH, Nealon RS, Scholey A, Howe PR.

Nutr Metab Cardiovasc Dis. 2016 Mar 14. pii: S0939-4753(16)00045-4. doi: 10.1016/j.numecd.2016.03.003. [Epub ahead of print]

PMID:
27105868
6.
7.

Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model.

Shrestha N, Araújo F, Shahbazi MA, Mäkilä E, Gomes MJ, Airavaara M, Kauppinen EI, Raula J, Salonen J, Hirvonen J, Sarmento B, Santos HA.

J Control Release. 2016 Apr 16;232:113-119. doi: 10.1016/j.jconrel.2016.04.024. [Epub ahead of print]

PMID:
27091697
8.

Cost effectiveness and value of information analyses of islet cell transplantation in the management of 'unstable' type 1 diabetes mellitus.

Wallner K, Shapiro AM, Senior PA, McCabe C.

BMC Endocr Disord. 2016 Apr 9;16(1):17. doi: 10.1186/s12902-016-0097-7.

9.

One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry).

Colombo A, Godino C, Donahue M, Testa L, Chiarito M, Pavon AG, Colantonio R, Cappelletti A, Monello A, Magni V, Milazzo D, Parisi R, Nicolino A, Moshiri S, Fattori R, Aprigliano G, Palloshi A, Caramanno G, Montorfano M, Bedogni F, Margonato A, Briguori C.

Int J Cardiol. 2016 Mar 24;214:113-120. doi: 10.1016/j.ijcard.2016.03.088. [Epub ahead of print]

PMID:
27060269
10.

Insulin-sensitive adiposity is associated with a relatively lower risk of diabetes than insulin-resistant adiposity: the Bogalusa Heart Study.

Zhang T, Li Y, Zhang H, Sun D, Li S, Fernandez C, Harville E, Bazzano L, He J, Chen W.

Endocrine. 2016 Apr 8. [Epub ahead of print]

PMID:
27060004
11.

Effects of multiple ascending doses of the glucagon receptor antagonist, PF-06291874, in patients with type 2 diabetes mellitus.

Kazierad DJ, Bergman A, Tan B, Erion DM, Somayaji V, Lee DS, Rolph T.

Diabetes Obes Metab. 2016 Apr 5. doi: 10.1111/dom.12672. [Epub ahead of print]

PMID:
27059951
12.

Impact and characteristics of the non-Caucasian population in hospital admissions for diabetes onset during 2003-2010.

San José P, Guerrero M, García-Martín I, Caballero J, Pérez-Maraver M.

Endocrinol Nutr. 2016 Apr 4. pii: S1575-0922(16)30016-X. doi: 10.1016/j.endonu.2016.01.007. [Epub ahead of print] English, Spanish.

PMID:
27055747
14.

Identification and evaluation of magnolol and chrysophanol as the principle protein tyrosine phosphatase-1B inhibitory compounds in a Kampo medicine, Masiningan.

Onoda T, Li W, Sasaki T, Miyake M, Higai K, Koike K.

J Ethnopharmacol. 2016 Apr 2. pii: S0378-8741(16)30175-1. doi: 10.1016/j.jep.2016.03.063. [Epub ahead of print]

PMID:
27049294
15.

Inhibition of the inflammasome NLRP3 by arglabin attenuates inflammation, protects pancreatic β-cells from apoptosis, and prevents type 2 diabetes mellitus development in ApoE2.Ki mice on a chronic high-fat diet.

Abderrazak A, El Hadri K, Bosc E, Blondeau B, Slimane MN, Buchele B, Simmet T, Couchie D, Rouis M.

J Pharmacol Exp Ther. 2016 Apr 4. pii: jpet.116.232934. [Epub ahead of print]

16.

The Need for Patient Follow-up Strategies to Confirm Diabetes Mellitus in Large Scale Opportunistic Screening.

Savitha AK, Gopalakrishnan S, Umadevi R, Rama R.

J Clin Diagn Res. 2016 Feb;10(2):LE01-4. doi: 10.7860/JCDR/2016/16320.7314. Epub 2016 Feb 1. Review.

17.

Association between glycemic control and morning blood surge with vascular endothelial dysfunction in type 2 diabetes mellitus patients.

Nuthalapati RK, Indukuri BR.

Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):182-8. doi: 10.4103/2230-8210.176349.

18.

Phenotyping of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: Results of a two-step cluster analysis.

Amato MC, Pizzolanti G, Torregrossa V, Pantò F, Giordano C.

J Diabetes Investig. 2016 Mar;7(2):219-25. doi: 10.1111/jdi.12398. Epub 2015 Sep 8.

19.

Pancreatic volume is reduced in patients with latent autoimmune diabetes in adults (LADA).

Lu J, Hou X, Pang C, Zhang L, Hu C, Zhao J, Bao Y, Jia W.

Diabetes Metab Res Rev. 2016 Apr 2. doi: 10.1002/dmrr.2806. [Epub ahead of print]

PMID:
27037998
20.

Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes.

Lepedda AJ, Lobina O, Rocchiccioli S, Nieddu G, Ucciferri N, De Muro P, Idini M, Nguyen HQ, Guarino A, Spirito R, Formato M.

J Diabetes Complications. 2016 Mar 12. pii: S1056-8727(16)30044-7. doi: 10.1016/j.jdiacomp.2016.03.007. [Epub ahead of print]

PMID:
27037039
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk